Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat

Brain Research

Volumn 770, Issue 1-2, 1997, Pages 277-288

  Mönnikes, Hubert ^a   Lauer, Gerd ^a   Arnold, Rudolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Area postrema; Autonomic nervous system; Brain gut axis; Nucleus of the solitary tract; Stress; Subcoeruleus nucleus

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CAPSAICIN; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; AUTONOMIC DENERVATION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT FUNCTION; GENE EXPRESSION; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; LOCUS CERULEUS; MALE; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS; STRESS; VAGUS NERVE;

ANIMALS; CAPSAICIN; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; LOCUS COERULEUS; MALE; NEURONS, AFFERENT; NOOTROPIC AGENTS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; SINCALIDE; SOLITARY NUCLEUS; STRESS; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; VAGUS NERVE;

EID: 17044441490     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00865-2     Document Type: Article

References (67)

1. Bonaz B., Martin L., Beurriand E., Manier M., Hostein J., Feuerstein C. Locus coeruleus modulates migrating myoelectric complex in rats. Am. J. Physiol. 262:1992;G1121-G1126.
2. Bonham A.C., Hasser E.M. Area postrema and aortic or vagal afferents converge to excite cells in nucleus tractus solitarius. Am. J. Physiol. Heart Circ. Physiol. 264:1993;H1674-H1685.
3. Bradwejn J., Koszycki D., Payeur R. Role of cholecystokinin in irritable bowel syndrome. Am. J. Psychiatry. 148:1991;277.
4. Buck S.H., Burks T.F. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol. Rev. 38:1986;179-250.
5. Butler P.D., Weiss J.M., Stout J.C., Nemeroff C.B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci. 10:1990;176-183.
6. Ceccatelli S., Villar M.J., Goldstein M., Hokfelt T. Expression of c-fos immunoreactivity in transmitter-characterized neurons after stress. Proc. Natl. Acad. Sci. USA. 86:1989;9569-9573.
7. Cedarbaum J.M., Aghajanian G.K. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol. 178:1978;1-16.
8. Chen D.Y., Deutsch J.A., Gonzalez M.F., Gu Y. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718. Neurosci. Lett. 149:1993;91-94.
9. Clark F.M., Proudfit H.K. The projection of locus coeruleus neurons to the spinal cord in the rat determined by anterograde tracing combined with immunocytochemistry. Brain Res. 538:1991;231-245.
10. Corp E.S., McQuade J., Moran T.H., Smith G.P. Characterization of type A and type B receptor binding sites in rat vagus nerve. Brain Res. 623:1993;161-166.
11. Curtis A.L., Drolet G., Valentino R.J. Hemodynamic stress activates locus coeruleus neurons of unanesthetized rats. Brain Res. Bull. 31:1993;737-744.
12. Curtis A.L., Valentino R.J. Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons. Psychopharmacology. 103:1991;330-338.
13. Day H.E., McKnight A.T., Poat J.A., Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology. 33:1994;719-727.
14. G.J. Dockray, Vagally mediated actions of CCK, in: G. Adler, C. Beglinger (Eds.), Cholecystokinin Antagonists in Gastroenterology, Springer-Verlag, Berlin - Heidelberg, 1991, pp. 56-64.
15. W.R. Ewart, Medullary integration of afferent information from the gastrointestinal tract, in: Y. Tache, D.L. Wingate (Eds.), Brain-Gut Interactions, CRC Press, Boca Raton, 1991, pp. 109-121.
16. Fraser K.A., Davison J.S. Cholecystokinin-induced c-fos expression in the rat brain stem is influenced by vagal nerve integrity. Exp. Physiol. 77:1992;225-228.
17. Fraser K.A., Davison J.S. Meal-induced c-fos expression in brain stem is not dependent on cholecystokinin release. Am. J. Physiol. 265:1993;R235-R239.
18. Hay M., Bishop V.S. Effects of area postrema stimulation on neurones of the nucleus of the solitary tract. Am. J. Physiol. 260:1991;H1359-H1364.
19. Hill F.L., Campbell N.J., Shaw T.M., Woodruft G.N. Autoradiographic localization and biochemical characterisation of peripheral type CCK receptors in rat CNS using highly selective non-peptide CCK-antagonists. J. Neurosci. 7:1987;2967-2976.
20. Hoffman G.E., Smith M.S., Verbalis J.G. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front. Neuroendocrinol. 14:1993;173-213.
21. R.T. Jensen, J.D. Gardner, Cholecystokinin receptor antagonists in vitro, in: G. Adler, C. Beglinger (Eds.), Cholecystokinin Antagonists in Gastroenterology, Springer-Verlag, Berlin - Heidelberg, 1991, pp. 93-111.
22. Johnson A.K., Gross P.M. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 7:1993;678-686.
23. Koop H., Mönnikes H., Koop I., Dionysius J., Schwarz C., Arnold R. Effect of the prokinetic drug cisapride on gastrointestinal hormone release. Scand. J. Gastroenterol. 8:1986;907-913.
24. Li B.H., Rowland N.E. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain. Regul. Pept. 50:1994;223-233.
25. Li B.H., Rowland N.E. Effects of vagotomy on cholecystokinin- and dexfenfluramine-induced Fos-like immunoreactivity in the rat brain. Brain Res. Bull. 37:1995;589-593.
26. Li H.Y., Ericsson A., Sawchenko P.E. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc. Natl. Acad. Sci. USA. 93:1996;2359-2364.
27. Li Y., Owyang C. Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J. Clin. Invest. 92:1993;418-424.
28. S.E. Loughlin, J.H. Fallon, Locus coeruleus, in: G. Paxinos (Ed.) The Rat Nervous System, Academic Press, Orlando, 1985, pp. 79-93.
29. Loughlin S.E., Foote S.L., Bloom F.E. Efferent projections of nucleus locus coeruleus: topographic organization of cells of origin demonstrated by three-dimensional reconstruction. Neuroscience. 2:1986;291-306.
30. Luckman S.M. Fos-like immunoreactivity in the brainstem of the rat following peripheral administration of cholecystokinin. J. Neuroendocrinol. 4:1992;149-152.
31. Luckman S.M., Hamamura M., Antonijevic I., Dye S., Leng G. Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion. Br. J. Pharmacol. 110:1993;378-384.
32. Maeda T., Kojima Y., Arai R., Fujimiya M., Kimura H., Kitahama K., Geffard M. Monoaminergic interaction in the central nervous system: a morphological analysis in the locus coeruleus of the rat. Comp. Biochem. Physiol. [C]. 98C:1991;193-202.
33. McBridge R.L., Sutin J. Projections of the locus coeruleus and adjacent pontine tegmentum in the cat. J. Comp. Neurol. 165:1975;265-284.
34. M.J. McCann, R.C. Rogers, Central modulation of the vagovagal reflex: influence on gastric function, in: Y. Tache, D.L. Wingate (Eds.), Brain-Gut Interactions, CRC Press, Boca Raton, 1991, pp. 57-69.
35. Mercer J.G., Farningham D.A.H., Lawrence C.B. Effect of neonatal capsaicin treatment on cholecystokinin-(CCK8) satiety and axonal transport of CCK binding sites in the rat vagus nerve. Brain Res. 569:1992;311-316.
36. L.J. Miller, Heterogenity of CCK receptors: classification and characterisation, in: G. Adler, C. Beglinger (Eds.), Cholecystokinin Antagonists in Gastroenterology, Springer-Verlag, Berlin - Heidelberg, 1991, pp. 27-35.
37. Mönnikes H., Schmidt B.G., Raybould H.E., Tache Y. CRF in the paraventricular nucleus mediates gastric and colonic motor response to restraint stress. Am. J. Physiol. 262:1992;G137-G143.
38. Mönnikes H., Schmidt B.G., Tebbe J., Bauer C., Tache Y. Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats. Brain Res. 644:1994;101-108.
39. Mönnikes H., Tebbe J., Bauer C., Lauer G., Arnold R. Microinfusion of corticotropin-releasing factor into the locus coeruleus/subcoeruleus nuclei inhibits gastric acid secretion via spinal pathways in the rat. Brain Res. 728:1996;157-165.
40. Moran T.H., McHugh P.R. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am. J. Physiol. 242:1982;R491-R497.
41. Moran T.H., Norgren R., Crosby R.J., McHugh P.R. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers. Brain Res. 526:1990;95-102.
42. Olson B.R., Verbalis J.G., Sved A.F., Stricker E.M., Hoffman G.E. CCK activates c-fos in paraventricular neurons projecting to the dorsal vagal complex. Soc. Neurosci. Abstr. 16:1990;A866.
43. Olson L., Fuxe K. Further mapping out of central noradrenaline neuron systems: projections of the 'subcoeruleus' area. Brain Res. 43:1972;289-295.
44. Onaka T., Luckman S.M., Antonijevic I., Palmer J.R., Leng G. Involvement of the noradrenergic afferents from the nucleus tractus solitarii to the supraoptic nucleus in oxytocin release after peripheral cholecystokinin octapeptide in the rat. Neuroscience. 66:1995;403-412.
45. G. Paxinos, C. Watson, The Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1982, pp. 1-82.
46. Petrov T., Krukoff T.L., Jhamandas J.H. Branching projections of catecholaminergic brainstem neurons to the paraventricular hypothalamic nucleus and the central nucleus of the amygdala in the rat. Brain Res. 609:1993;81-92.
47. Raybould H.E., Gayton R.J., Dockray G.J. Mechanism of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat. J. Neurosci. 8:1988;3018-3024.
48. Raybould H.E., Lloyd K.C. Integration of postprandial function in the proximal gastrointestinal tract. Role of CCK and sensory pathways. Ann. NY Acad. Sci. 713:1994;143-156.
49. Raybould H.E., Taché Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am. J. Physiol. 255:1988;G242-G246.
50. Rinaman L., Hoffman G.E., Dohanics J., Le W.W., Stricker E.M., Verbalis J.G. Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats. J. Comp. Neurol. 360:1995;246-256.
51. Rinaman L., Verbalis J.G., Stricker E.M., Hoffman G.E. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin. J. Comp. Neurol. 338:1993;475-490.
52. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
53. Saito A., Sankaran H., Goldfine I.D., Williams J.A. Cholecystokinin receptors in brain: characterization and distribution. Science. 208:1980;1155-1156.
54. Schwartz G.J., Moran T.H. CCK elicits and modulates vagal afferent activity arising from gastric and duodenal sites. Ann. NY Acad. Sci. 713:1994;121-128.
55. Schwartz G.J., Tougas G., Moran T.H. Integration of vagal afferent responses to duodenal loads and exogenous CCK in rats. Peptides. 16:1995;707-711.
56. Smith D.W., Trevor A.D. Neurochemical identification of fos-positive neurons using two-colour immunoperoxidase staining. J. Neurosci. Methods. 47:1993;73-83.
57. Smith G.P., Jerome C., Cushin B.J., Eterno R., Simansky K.J. Afferent axons in the abdominal vagus mediate the satiety effect of cholecystokinin in the rat. Am. J. Physiol. 249:1981;R638-R641.
58. Y. Taché, H. Mönnikes, B. Bonaz, J. Rivier, Role of CRF in stress-related alterations of gastric and colonic motor function, in: Y. Taché (Ed.), CRF and Cytokines: Role in the Stress Response, The New York Academy of Sciences, New York, 1993, pp. 233-243.
59. Y. Taché, H. Mönnikes, CRF in the central nervous system mediates stress-induced stimulation of colonic motor function: relevance to the pathophysiology of IBS, in E.A. Mayer, H.E. Raybould (Eds.), Basic and Clinical Aspects of Chronic Abdominal Pain, Elsevier, Amsterdam, 1993, pp. 141-151.
60. R.J. Valentino, CRH effects on central noradrenergic neurons: relationship to stress, in: G.P. Chrousos, D.L. Loriaux, P.W. Gold (Eds.), Mechanisms of Physical and Emotional Stress, Plenum Press, New York, 1988, pp. 47-64.
61. R.J. Valentino, Effects of CRF on spontaneous and sensory-evoked activity of locus coeruleus neurons, in: E.B. De Souza, C.B. Nemeroff (Eds.), Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide, CRC Press, Boca Raton, 1990, pp. 217-231.
62. Valentino R.J., Foote S.L., Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann. NY Acad. Sci. 697:1993;173-189.
63. J.G. Verbalis, L. Rinaman, G.E. Hoffman, E.M. Stricker, Functional neural connections between the hypothalamus and the dorsal vagal complex, in: M.V. Singer, R. Ziegler, G. Rohr (Eds.), Gastrointestinal Tract and Endocrine System, Kluwer Academic Publishers, Dordrecht, 1995, pp. 3-16.
64. Verbalis J.G., Stricker E.M., Robinson A.G., Hoffman G.E. Cholecystokinin activates c-fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurones. J. Neuroendocrinol. 3:1991;205-213.
65. Walker E.A., Roy-Byrne P.P., Katon W.J. Irritable bowel syndrome and psychiatric illness. Am. J. Psychiatry. 147:1990;565-572.
66. Wallace D.M., Magnuson D.J., Gray T.S. Organization of amygdaloid projections to brainstem dopaminergic, noradrenergic, and adrenergic cell groups in the rat. Brain Res. Bull. 28:1992;447-454.
67. R.Y. Wang, C.R. Ashby, Biological actions of CCK in the central nervous system, in: G. Adler, C. Beglinger (Eds.), Cholecystokinin Antagonists in Gastroenterology, Springer-Verlag, Berlin - Heidelberg, 1991, pp. 44-55.